Healionics’ STARgraft Receives FDA Breakthrough Device Designation
/
DateNov 14 2024
SEATTLE, WA, UNITED STATES, November 14, 2024 /EINPresswire.com/ — Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that its STARgraft arteriovenous graft... Read More →